Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Appointed CFO
Quarterly results
Acq. announced
Director departure
CC transcript
MGI PHARMA INC (MOGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/28/2008 8-K Quarterly results
01/23/2008 8-K Changes in Control of Registrant, Financial Statements and Exhibits
12/27/2007 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...
Docs: "Amendment No. 2 to Rights Agreement, effective as of December 20, 2007, between MGI PHARMA, INC. and Wells Fargo Bank, N.A",
"NOTICE OF CONVERSION RIGHT FOR SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2024"
12/11/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Eisai Co., Ltd., Jaguar Acquisition Corp. and MGI PHARMA, INC",
"EISAI TO ACQUIRE MGI PHARMA FOR $41 PER SHARE IN AN ALL CASH TRANSACTION"
10/17/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports Third Quarter 2007 Financial Results"
10/12/2007 8-K/A Cost Associated with Exit or Disposal Activities
09/27/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "MGI PHARMA ANNOUNCES SUBMISSION OF AQUAVAN"
08/30/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger dated August 28, 2007, including the form of Stockholder Support and Option Agreement as Schedule A thereto (The Company has omitted certain schedules in accordance with Regulation S-K 6501(b)(2). The Company will submit the omitted schedules to the Commission upon request.)"
07/18/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports Second Quarter 2007 Financial Results"
04/18/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports First Quarter 2007 Financial Results"
03/01/2007 8-K Results of Operations and Financial Condition, Non-Reliance on Previously Issued Financial Statements or a Related Audit Repo...
Docs: "MGI PHARMA AMENDS QUARTERLY FILINGS FOR SECOND AND THIRD QUARTERS OF 2006"
02/07/2007 8-K Quarterly results
Docs: "MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results"
01/10/2007 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "MGI PHARMA, INC. slide presentation for the JP Morgan 25th Annual Healthcare Conference on January 10, 2007"
11/01/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MGI PHARMA ANNOUNCES SPECIFIC J CODE ASSIGNMENT FOR DACOGEN™"
10/26/2006 8-K Cost Associated with Exit or Disposal Activities
10/24/2006 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Credit Agreement, among MGI PHARMA, INC., as a Borrower, MGI GP, Inc., as a Borrower, MGI OM, Inc., as a Borrower, the Other Loan Parties, the Lenders Party hereto, and JPMorgan Chase Bank, N.A., as Administrative Agent, Sole Bookrunner and Sole Lead Arranger",
"Pledge and Security Agreement, by and between, MGI PHARMA, INC., MGI GP, Inc., MGI OM, Inc., MGI PHARMA Biologics, Inc., ProQuest Pharmaceuticals, Inc., MGI Products, Inc., MGI MSL, LLC, MGI (Canada) Inc., GPI IP, LLC, and JPMorgan Chase Bank, N.A., as administrative agent"
10/18/2006 8-K Quarterly results
Docs: "MGI PHARMA Reports Third Quarter 2006 Financial Results"
10/16/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "MGI PHARMA RECEIVES APPROVABLE LETTER FOR SAFORIS™ POWDER IN UPTEC™ FOR ORAL SUSPENSION"
09/26/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slide Presentation of September 26, 2006 at the UBS Global Life Sciences Conference"
08/11/2006 8-K Asset disposition
08/07/2006 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "MGI PHARMA ANNOUNCES EXECUTIVE APPOINTMENTS"
07/27/2006 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "DR. JAMES ARMITAGE APPOINTED TO MGI PHARMA BOARD OF DIRECTORS"
07/26/2006 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Script for July 19, 2006, conference call announcing financial results for the period ended June 30, 2006"
07/19/2006 8-K Quarterly results
Docs: "MGI PHARMA REPORTS SECOND QUARTER 2006 FINANCIAL RESULTS"
07/10/2006 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "MGI PHARMA ANNOUNCES LICENSE AGREEMENT WITH CILAG GMBH, A JOHNSON & JOHNSON COMPANY, FOR DACOGEN™ FOR INJECTION"
04/27/2006 8-K Appointed CFO
Docs: "Termination Agreement between MGI PHARMA, INC. and William F. Spengler",
"Severance Agreement and General Release between MGI PHARMA, Inc. and James Hawley"
04/19/2006 8-K Quarterly results
Docs: "MGI PHARMA REPORTS FIRST QUARTER 2006 FINANCIAL RESULTS —First Quarter Highlighted by Execution of Pipeline Initiatives"
04/14/2006 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "MGI PHARMA UPDATES OUTLOOK FOR FIRST QUARTER"
02/09/2006 8-K/A Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CORRECTING AND REPLACING: MGI PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2005 FINANCIAL RESULTS"
02/08/2006 8-K Quarterly results
Docs: "PRESS RELEASE ANNOUNCING FINANCIAL RESULTS"
01/24/2006 8-K Entry into a Material Definitive Agreement
01/10/2006 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "MGI PHARMA PROVIDES CORPORATE UPDATE"
11/29/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "MGI PHARMA ANNOUNCES EXPIRATION OF TENDER OFFER FOR GUILFORD PHARMACEUTICALS NOTES DUE 2008"
11/14/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Form of Lock-Up Agreement"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy